Universität Wien

320056 VO Innovation und Leadership (2015S)

1.00 ECTS (2.00 SWS), SPL 32 - Pharmazie

Keine LV-Anmeldung notwendig! Seminarraum 2D313

Details

Sprache: Englisch

Prüfungstermine

Lehrende

Termine (iCal) - nächster Termin ist mit N markiert

  • Montag 16.03. 15:00 - 16:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 18.03. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 20.03. 15:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 27.03. 15:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 15.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 17.04. 15:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 22.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 24.04. 15:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 29.04. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Mittwoch 06.05. 18:30 - 20:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Freitag 08.05. 15:00 - 17:00 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II
  • Montag 11.05. 15:00 - 16:30 Seminarraum Arzneistoffsynthese 2D313 3.OG UZA II

Information

Ziele, Inhalte und Methode der Lehrveranstaltung

The pharmaceutical industry has been criticized for its recent lack of innovation. However, it has produced impressive breakthroughs such as, insulin, first in class vaccines, antihistamines, antibiotics, hormone, retroviral and cancer therapies that have significantly impacted our society. Furthermore, rapid advances in technology, infrastructure and manufacturing processes have resulted due to advancing research and development needs throughout the evolving process of designing new therapies. From this perspective, what exactly does lack of innovation mean? On the surface the need to ‘be innovative’ seems obvious. However, the process of generating ideas, finding novel solutions to problems, and meeting unarticulated needs by introducing disruptive technologies, and services to the market is extremely challenging and often results in failure.

Art der Leistungskontrolle und erlaubte Hilfsmittel

Mindestanforderungen und Beurteilungsmaßstab

This course will introduce the concept of innovation and disruptive technology as well as review exemplary innovators in health care and other industries. In addition, we will interactively experience the process of innovation in the context of a project related to pharmaceutical science that will provide a framework to explore the unique leadership competencies required to guide and shape creative teams and inspire the imagination needed to recognize a good idea and transform it into a useful or even disruptive technology.

Prüfungsstoff

Literatur

Zuordnung im Vorlesungsverzeichnis

A 400

Letzte Änderung: Sa 02.04.2022 00:27